Literature DB >> 15136545

Does perioperative oral rofecoxib therapy improve functional recovery after knee replacement surgery?

Mohit Bhandari1.   

Abstract

Entities:  

Year:  2004        PMID： 15136545      PMCID： PMC400716          DOI： 10.1503/cmaj.1040499

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Preoperative oral rofecoxib does not decrease postoperative pain or morphine consumption in patients after radical prostatectomy: a prospective, randomized, double-blinded, placebo-controlled trial.

Authors:  J J Huang; A Taguchi; H Hsu; G L Andriole; A Kurz
Journal:  J Clin Anesth       Date:  2001-03       Impact factor: 9.452

2.  The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty.

Authors:  Lowell W Reynolds; Robert K Hoo; Robert J Brill; Janine North; David P Recker; Kenneth M Verburg
Journal:  J Pain Symptom Manage       Date:  2003-02       Impact factor: 3.612

3.  Cyclo-oxygenase 2 function is essential for bone fracture healing.

Authors:  Ann Marie Simon; Michaele Beth Manigrasso; J Patrick O'Connor
Journal:  J Bone Miner Res       Date:  2002-06       Impact factor: 6.741

4.  Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty.

Authors:  T Philip Malan; Gregory Marsh; Sam I Hakki; Evie Grossman; Louise Traylor; Richard C Hubbard
Journal:  Anesthesiology       Date:  2003-04       Impact factor: 7.892
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.